Aeterna Zentaris Research Coverage Started at StockNews.com
| AEZSDelisted Stock | USD 6.14 0.08 1.29% |
Slightly above 62% of AEZS Old's investor base is looking to short. The analysis of current outlook of investing in AEZS Old suggests that many traders are alarmed regarding AEZS Old's prospects. AEZS Old's investing sentiment can be driven by a variety of factors including economic data, AEZS Old's earnings reports, geopolitical events, and overall market trends.
AEZS |
StockNews.com assumed coverage on shares of Aeterna Zentaris in a report published on Friday. The brokerage issued a sell rating on the biopharmaceutical companys stock. Separately, HC Wainwright restated a buy rating and set a 28.00 price objective on shares of Aeterna Zentaris in a report on Tuesday, March 28th.
Read at thelincolnianonline.com
 |
AEZS Old Fundamental Analysis
We analyze AEZS Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AEZS Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AEZS Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
AEZS Old is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
AEZS Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AEZS Old stock to make a market-neutral strategy. Peer analysis of AEZS Old could also be used in its relative valuation, which is a method of valuing AEZS Old by comparing valuation metrics with similar companies.
Peers
AEZS Old Related Equities
| RNAZ | Transcode Therapeutics | 24.64 | ||||
| PULM | Pulmatrix | 11.13 | ||||
| ATXI | Avenue Therapeutics | 8.09 | ||||
| TNXP | Tonix Pharmaceuticals | 1.84 | ||||
| IBIO | Ibio | 0.98 | ||||
| ADTX | Aditxt | 0.91 | ||||
| ADIL | Adial Pharmaceuticals | 0 | ||||
| RVPH | Reviva Pharmaceuticals | 0.52 | ||||
| MBRX | Moleculin Biotech | 0.57 | ||||
| JAGX | Jaguar Animal | 1.33 | ||||
| BPTH | Bio Path | 4.02 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in AEZS Stock
If you are still planning to invest in AEZS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AEZS Old's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |